PT 141 Peptide

PT-141, also known as Bremelanotide, is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). It has attracted significant scientific interest due to its interaction with melanocortin receptors and its association with neurobiological signalling pathways.

Researchers have investigated PT-141 across a variety of experimental models examining receptor-mediated communication systems, central nervous system signalling, and broader biological regulatory mechanisms. Its selective interaction with melanocortin pathways has made it a frequently referenced compound within peptide research literature.

Research Overview

PT-141 is commonly studied in relation to:

• Melanocortin receptor signalling investigations
• Neurobiological communication pathway research
• Central nervous system research models
• Peptide-receptor interaction studies
• Energy balance and metabolic signalling investigations
• Cellular communication and biological regulation research

As a synthetic analogue of α-MSH, PT-141 continues to be examined in studies focused on receptor signalling networks and complex neurobiological processes.

Key Characteristics

• Synthetic peptide analogue of α-MSH
• Purity ≥98% (HPLC verified)
• Supplied as lyophilised powder
• Frequently studied in melanocortin receptor research
• Suitable for laboratory and scientific research applications

Product Specifications

• Available quantities: 10mg, 50mg, and 100mg
• Lyophilised powder format
• Purity ≥98% (HPLC verified)
• Store in a cool, dry place
• Reconstituted solutions should be refrigerated

Important Information

• Supplied for research purposes only
• Not for human or veterinary use
• Not intended for consumption
• This product is not intended to diagnose, treat, cure, or prevent any disease
• Purchasers are responsible for ensuring compliance with local laws and regulations